Form 4: Gevo CFO Receives Substantial Equity Compensation Package

Gevo, Inc.'s Chief Financial Officer, Oluwagbemileke Yusuf Agiri, was granted 189,084 shares of restricted common stock and 563,981 stock options as part of his compensation package.

Summary

• Gevo, Inc.'s Chief Financial Officer, Oluwagbemileke Yusuf Agiri, acquired 189,084 shares of restricted common stock on June 9, 2025.
• These restricted shares were granted at a price of $0 and will vest in three equal annual installments, contingent on continuous service.
• Mr. Agiri's beneficial ownership of common stock following this transaction is 341,224 shares directly and 18,992.5 shares indirectly through a 401(k) Plan.
• Additionally, the CFO was granted 563,981 stock options with an exercise price of $1.18 per share on June 9, 2025.
• These stock options also vest in three equal annual installments beginning on the first anniversary of the grant date, provided continuous service is maintained.
• The stock options have an expiration date of June 8, 2035.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities, intended to satisfy Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: The grant of equity awards to the CFO aligns his long-term interests with those of the shareholders and serves as a retention mechanism, which is generally viewed favorably. While there's potential for dilution, it's a standard and often positive aspect of executive compensation.

Positives

• The grant of restricted stock and stock options aligns the Chief Financial Officer's long-term interests with those of the shareholders, incentivizing performance and value creation.
• Equity compensation serves as a strong retention tool for key executives, ensuring continuity in leadership.
• The use of a Rule 10b5-1 plan indicates a pre-arranged transaction, which can provide transparency and reduce concerns about opportunistic insider trading.

Negatives

• The issuance of new shares and options, upon vesting and exercise, could lead to potential dilution for existing shareholders, although this is a common aspect of equity compensation plans.

Risks

• The vesting of both restricted common stock and stock options is contingent upon the reporting person remaining in continuous service with Gevo, Inc. as of each vesting date, meaning the awards could be forfeited if employment ceases.

Future Outlook

The future outlook for the granted equity awards is tied to the CFO's continuous service with Gevo, Inc. and the company's stock performance. The restricted stock and stock options are designed to vest over three years, aligning the CFO's incentives with the company's long-term success.

Management Comments

• The filing indicates that the transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Industry Context

The grant of equity compensation, including restricted stock and stock options, to key executives like the CFO is a standard practice across various industries, particularly in growth-oriented companies. This approach is widely used to attract, retain, and incentivize top talent by aligning their financial interests with the long-term performance of the company and its shareholders.

Comparison to Industry Standards

• The structure of this equity grant, involving restricted stock and stock options with multi-year vesting schedules, is consistent with common executive compensation practices observed in publicly traded companies, including those in the renewable fuels and biotechnology sectors.
• Companies such as Amyris, Inc. (AMRS) or Aemetis, Inc. (AMTX), also operating in the renewable fuels space, frequently utilize similar equity-based incentive programs for their executive teams to foster long-term commitment and performance.

Related Party Transactions

• The grant of restricted common stock and stock options to Oluwagbemileke Yusuf Agiri, the Chief Financial Officer, constitutes a related party transaction as it involves compensation from the issuer to a key executive.

Stakeholder Impact

• Shareholders: Potential for future dilution upon vesting and exercise of equity awards, but also benefit from aligned management incentives and executive retention.
• Employees (CFO): Direct financial benefit through equity compensation, contingent on continued employment and company performance.

Next Steps

• The restricted common stock and stock options will begin to vest in three equal annual installments starting on the first anniversary of the grant date (June 9, 2025), contingent on the CFO's continuous service.

Key Dates

Recommendation

Keywords

Gevo, GEVO, SEC Form 4, Insider Transaction, Executive Compensation, Stock Grant, Stock Options, Restricted Stock, Equity Awards, CFO, Corporate Governance